Jungbunzlauer and Green Biologics Partner on Bio-Based Plasticizers
Ashland, USA and Abingdon, UK: 14 February 14 2017 - Green Biologics, Inc., the US subsidiary of Green Biologics Ltd., a UK industrial biotechnology and renewable chemicals company, announced today an exclusive collaboration with Jungbunzlauer Ladenburg GmbH, the German operating unit of Jungbunzlauer Suisse AG in Basel, Switzerland. In February 2017, Jungbunzlauer received its first shipment of 100 percent renewable BioPureTM n-butanol from Green Biologics' production facility in Little Falls, Minnesota. Jungbunzlauer aims to produce bio-based CITROFOL® BI (tributyl citrate) and bio-based CITROFOL® BII (acetyl tributyl citrate) for its customers with commercial shipments beginning next month.
More information on Green Biologics' website.
Next > Trod Medical is mentioned in Medical Device Daily
Previous > Avantium announces intention to launch Initial Public Offering and listing on Euronext Amsterdam and Euronext Brussels